Skip to content


Webinar 2.11.2021

Health Tuesday: The promise and current status of digital therapeutics

At 8:00-10:15

More information

Sampo Sammalisto
Head of Personalized Health Finland Program
sampo.sammalisto (at)
+358 50 584 1100

Digital therapeutics (DTx) is an exciting and growing field of are evidence-based therapies that complement pharmaceutical therapies and are typically employed in the prevention and management of chronic diseases and conditions such as diabetes, obesity, asthma and depression.

As digital therapies collect data from the patient, they can be optimized for an individual patient while also collecting data for developing the therapies for future patients and accumulating data to measure outcomes for payers.

If you want to learn more about this exciting and rapidly growing area, join our Health Tuesday event.


8.00 Opening Words
Sampo Sammalisto, Head of Personalized Health Finland, Business Finland

8.05 The promise of Digital Therapeutics
Johannes Ahlqvist, Specialist, Health Data, Sitra

8.20 Digital therapeutics (DTx) - Case examples from novel treatment modalities
Anssi Mäkiniemi, Head of X Lab, Orion

8.35 Taking Remote Monitoring to Digital Therapeutics
Tuomas Mäkynen, CEO and Co-founder, Orla DTx

9.00 Health Tuesday event ends

9.15 Market opportunities Roundtable: Opportunities and examples in the Israel Digital Healthcare ecosystem​

Israel HealthTech ecosystem shattered all previous records in H1/2021 when Digital Health companies fundraised over $1B and investments in Digital Therapeutics companies in H1/2021 was triple the total amount raised in 2020. It is also a home for nearly 700 digital health companies, has 180 active investors, 40 MNC with exposure to digital health, over 50 hubs including 19 accelerators.

Join us to hear more about the driving trends in Israel HealthTech ecosystem and what kind of opportunities it provides for Finnish HealthTech companies. We have a unique opportunity to hear these insights and more from Lena Rogovin, Senior Digital Health Analyst, Sector Lead from Startup Nation Central. We will also hear Israel market entry experiences from Finnish MedTech companies.


  • Welcome and introductions, Sami Jääskeläinen, Counsellor, Trade and Investments, Embassy of Finland in Israel

  • Israel Digital Healthcare ecosystem insights and trends, Lena Rogovin, Senior Digital Health Analyst, Sector Lead from Startup Nation Central

  • Finnish companies sharing their experiences from Israel:
    - Jori-Matti Savolainen, Chief Commercial Officer, NewIcon
    - Anna-Maria Henell, CEO and Co-founder, Disior

  • Q&A

10.15 Roundtable session ends

Please find the presentations below:

Opening words

Digital therapeutics (DTx) - Case examples from novel treatment modalities

Taking Remote Monitoring to Digital Therapeutics

Disior: Making Medical Imaging Intelligent